![Harald Poth](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Harald Poth
Voorzitter bij
Phenex Pharmaceuticals AG
Profiel
Harald Poth is currently the Chairman-Supervisory Board at Phenex Pharmaceuticals AG, Director at Acousia Therapeutics GmbH, and Senior Investment Manager at LBBW Venture Capital GmbH.
He holds a doctorate degree from the University of Hohenheim.
Actieve functies van Harald Poth
| Bedrijven | Functie | Begin |
|---|---|---|
LBBW Venture Capital GmbH
 LBBW Venture Capital GmbH Investment ManagersFinance LBBW Venture Capital invests in companies located in DACH region. The firm targets companies operating in the fields of disruptive information technology, life sciences, software, digital formation and fintech. It provides financing for seed and early stage capital requirements with an investment size up to EUR 3 million. | Private Equity Investor | - |
Phenex Pharmaceuticals AG
 Phenex Pharmaceuticals AG Pharmaceuticals: GenericHealth Technology Specializes in identification and analysis of selective drug candidates for nuclear receptors using its SNuRM technology | Voorzitter | - |
Acousia Therapeutics GmbH
 Acousia Therapeutics GmbH BiotechnologyHealth Technology Develops drugs for local application | Directeur/Bestuurslid | - |
Opleiding van Harald Poth
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
7
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
LBBW Venture Capital GmbH
LBBW Venture Capital GmbH Investment ManagersFinance LBBW Venture Capital invests in companies located in DACH region. The firm targets companies operating in the fields of disruptive information technology, life sciences, software, digital formation and fintech. It provides financing for seed and early stage capital requirements with an investment size up to EUR 3 million. | Finance |
University of Hohenheim
 University of Hohenheim Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Phenex Pharmaceuticals AG
Phenex Pharmaceuticals AG Pharmaceuticals: GenericHealth Technology Specializes in identification and analysis of selective drug candidates for nuclear receptors using its SNuRM technology | Health Technology |
Acousia Therapeutics GmbH
Acousia Therapeutics GmbH BiotechnologyHealth Technology Develops drugs for local application | Health Technology |
Kies MarketScreener 
